Oxymetazoline
- Half-Life (t½)
- IN: 6h
- Formula
- C16H24N2O
- Molecular Weight
- 260.38 g/mol
- Aliases
- Afrin
Pharmacological Mechanism
Imidazoline α1A + partial α2 adrenergic agonist — topical vasoconstrictor for nasal congestion. Rebound congestion (rhinitis medicamentosa) develops with use >3 days. Topical formulation also approved for adult facial rosacea erythema (Rhofade).
Half-Life & Elimination Curve (IN: 6h)
Elimination (IN)
- 0×t½0h100%
- 1×t½6h50%
- 2×t½12h25%
- 3×t½18h12.5%
- 4×t½24h6.3%
- 5×t½30h3.1%
Dosing Guidelines
- Intranasal (IN): Typical 0.05 mg
Target Organ Systems
- Cardiovascular System
- Integumentary System
Chemical Structure & Identifiers
- InChIKey: WYWIFABBXFUGLM-UHFFFAOYSA-N
- SMILES: CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C